Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease

Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease

Abstract Backgrounds Long non-coding RNA (LncRNA) have been reported to be involved in the pathogenesis of neurodegenerative diseases, but whether it can serve as a biomarker for Alzheimer disease (AD) is not yet known. Methods The present study selected four specific LncRNA (17A, 51A, BACE1 and BC2...

Full description

Bibliographic Details
Main Authors: Liang Feng, Yu-Ting Liao, Jin-Cai He, Cheng-Long Xie, Si-Yan Chen, Hui-Hui Fan, Zhi-Peng Su, Zhen Wang
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Neurology
Subjects:
Long non-coding RNA
Biomarker
Diagnosis
Alzheimer disease
Online Access:http://link.springer.com/article/10.1186/s12883-017-1008-x

Internet

http://link.springer.com/article/10.1186/s12883-017-1008-x

Similar Items